Search results for "Immune system"

showing 10 items of 2885 documents

Th9 cells, new players in adaptive immunity.

2014

Upon antigen-specific stimulation, naive CD4⁺ T cells have the potential to differentiate into various T helper (Th) cell subsets. Earlier models of Th cell differentiation focused on IFN-γ-producing Th1 cells and IL-4-secreting Th2 cells. The discovery of additional CD4⁺ Th cell subsets has extended our understanding of Th cell differentiation beyond this dichotomy. Among these is the recently described Th9 cell subset, which preferentially produces interleukin (IL)-9. Here, we review the latest developments in Th9 cell development and differentiation, focusing on contributing environmental signals, and discuss potential physiological and pathophysiological functions of these cells. We des…

Cellular differentiationImmunologyReceptors Antigen T-CellAdaptive ImmunityMiceT-Lymphocyte SubsetsTransforming Growth Factor betaNeoplasmsmedicineHypersensitivityImmunology and AllergyAnimalsHumansInterleukin 9Interleukin 4biologyCell growthLymphocyte differentiationInterleukin-9Models ImmunologicalReceptors Interleukin-2Transforming growth factor betaT helper cellT-Lymphocytes Helper-InducerAcquired immune systemReceptors Interleukin-4medicine.anatomical_structureImmunologyInterferon Regulatory Factorsbiology.proteinSignal TransductionTrends in immunology
researchProduct

Monocyte-derived dendritic cells of patients with coronary artery disease show an increased expression of costimulatory molecules CD40, CD80 and CD86…

2007

Background Atherosclerosis is a disease triggered by diverse exogenous stimuli and sustained by chronic inflammatory processes. Dendritic cells (DCs) are key regulatory antigen-presenting cells and play a crucial role in regulating the adaptive and innate immune system in any chronic inflammatory process. DCs are present in atherosclerotic lesions in the areas of the highest T-cell density. So far, their role in atherosclerosis has not been fully elucidated. We investigated the phenotypic properties of DCs in patients with coronary artery disease (CAD) in comparison to healthy individuals. Methods Peripheral blood monocytes were isolated from 50 patients with CAD and 19 healthy individuals …

Cellular differentiationchemical and pharmacologic phenomenaCoronary Artery DiseaseMonocytesFlow cytometryDownregulation and upregulationRisk FactorsMedicineHumansCD40 AntigensAgedRegulation of gene expressionCD86Innate immune systemCD40biologymedicine.diagnostic_testbusiness.industryhemic and immune systemsCell DifferentiationGeneral MedicineDendritic CellsMiddle AgedAtherosclerosisFlow CytometryC-Reactive ProteinGene Expression RegulationImmunologybiology.proteinB7-1 AntigenLeukocytes MononuclearB7-2 AntigenCardiology and Cardiovascular MedicinebusinessCD80Coronary artery disease
researchProduct

Aging and asthma: pathophysiological mechanisms

2003

Cellular immunityAllergyAgingbusiness.industryImmunologyRespiratory diseaseImmunitySettore MED/10 - Malattie Dell'Apparato Respiratoriomedicine.diseasePathophysiologyAsthmaPathogenesisImmune systemImmunopathologyImmune SystemImmunologymedicineImmunology and AllergyHumansbusinessLungAsthmaHuman
researchProduct

Particle-Mediated Gene Transfer into Dendritic Cells: A Novel Strategy for the Induction of Immune Responses against Tumor Antigens

2003

The expression of a foreign protein in the skin following direct in vivo gene transfer results in the induction of potent cellular and humoral immune responses. This strategy, now known as genetic or DNA immunization, was first described by Johnston et al. in 1992. They reported that bombardment of murine skin with an expression plasmid encoding human growth hormone coated onto microscopic gold particles using a gene gun resulted not only in the systemic delivery of the molecule, but also in the induction of antigenspecific antibody responses (1). It is now well established that DNA immunization by particle-mediated gene transfer promotes broad-based and long-lasting antigen-specific immune…

Cellular immunityImmune systemAntigenImmunizationFollicular dendritic cellsCancer researchCytotoxic T cellBiologyCD8Gene gun
researchProduct

Requirements for Th1-dependent immunity against infection with Leishmania major

2004

Protective immunity against cutaneous leishmaniasis is dependent on the induction of Th1/Tc1 immune responses resulting in efficient parasite elimination. In this review, the mechanisms leading to protection are discussed with special focus on the role of Leishmania major-infected dendritic cells (DC) in induction of Th1-dependent immunity. Murine strain-dependent differences between DC derived from Leishmania-susceptible as compared to resistant mice are highlighted.

Cellular immunityImmunologyLeishmaniasis CutaneousBiologyMicrobiologyMiceImmune systemCutaneous leishmaniasisImmunitymedicineAnimalsHumansLeishmania majorLeishmania majorAntigen PresentationMice Inbred BALB CDendritic CellsDendritic cellTh1 Cellsbiochemical phenomena metabolism and nutritionbiology.organism_classificationmedicine.diseaseLeishmaniaMice Inbred C57BLInfectious DiseasesImmunologyInterleukin 12Microbes and Infection
researchProduct

Circulating specific antibodies enhance systemic cross-priming by delivery of complexed antigen to dendritic cells in vivo

2012

Increasing evidence suggests that antibodies can have stimulatory effects on T-cell immunity. However, the contribution of circulating antigen-specific antibodies on MHC class I cross-priming in vivo has not been conclusively established. Here, we defined the role of circulating antibodies in cross-presentation of antigen to CD8(+) T cells. Mice with hapten-specific circulating antibodies, but naϊve for the T-cell antigen, were infused with haptenated antigen and CD8(+) T-cell induction was measured. Mice with circulating hapten-specific antibodies showed significantly enhanced cross-presentation of the injected antigen compared with mice that lacked these antibodies. The enhanced cross-pre…

Cellular immunityOvalbuminImmunologyMice Transgenicchemical and pharmacologic phenomenaAntigen-Antibody ComplexCD8-Positive T-LymphocytesBiologyDendritic cellsAntibodiesMiceCross-PrimingImmune systemAntigenAntigens NeoplasmMHC class ITcellsAnimalsImmunology and AllergyImmunity CellularB cellsCross-presentationHistocompatibility Antigens Class ICross-presentationSerum Albumin BovineFlow CytometryCD11c AntigenMice Inbred C57BLMacrophage-1 antigenHumoral immunityImmunologybiology.proteinAntibodyHaptensEuropean Journal of Immunology
researchProduct

Comparison between tumors in plants and human beings: Mechanisms of tumor development and therapy with secondary plant metabolites

2019

Abstract Background Human tumors are still a major threat to human health and plant tumors negatively affect agricultural yields. Both areas of research are developing largely independent of each other. Treatment of both plant and human tumors remains unsatisfactory and novel therapy options are urgently needed. Hypothesis The concept of this paper is to compare cellular and molecular mechanisms of tumor development in plants and human beings and to explore possibilities to develop novel treatment strategies based on bioactive secondary plant metabolites. The interdisciplinary discourse may unravel commonalities and differences in the biology of plant and human tumors as basis for rational …

Cellular immunityPhytochemicalsPlant TumorsPhysical CarcinogenesisSecondary MetabolismPharmaceutical ScienceBiologymedicine.disease_cause03 medical and health sciences0302 clinical medicineImmune systemCancer stem cellNeoplasmsDrug DiscoveryBiological CarcinogenesisPlant defense against herbivorymedicineAnimalsHumansPlant ImmunityPlant Physiological PhenomenaPlant Diseases030304 developmental biologyPharmacology0303 health sciencesAntibiotics Antineoplasticfungifood and beveragesPlantsAntineoplastic Agents PhytogenicComplementary and alternative medicineAgrobacterium tumefaciensDrug Resistance Neoplasm030220 oncology & carcinogenesisCancer researchMolecular MedicineCarcinogenesisPhytomedicine
researchProduct

The Human T Cell Response to Mitogenic Microbial Exotoxins

1991

Nearly every infectious pathogen has to cope with the host’s adaptive immune response. Common evasion mechanisms in this complex interaction are antigenic variations, the escape to immunologically privileged sites, or the use of immunosuppressive mechanisms. Many bacteria and other microorganisms elaborate soluble factors or toxins that act suppressively on cells of the immune system, such as pore-forming molecules or proteins that interfere with the function of G proteins. Gram-positive cocci and a mycoplasma have developed an extremely potent mechanism of T cell stimulation by closely mimicking recognition of specific antigen. From the functional similarity to antigen recognition and the …

Cellular immunityT cellT lymphocyteBiologymedicine.disease_causeAcquired immune systemMicrobiologyImmune systemmedicine.anatomical_structureAntigenImmunologymedicineSuperantigenExotoxin
researchProduct

Cellular immunity to the Her-2/neu protooncogene

2002

Her-2/neu (HER-2) is a 185-kDa receptor-like glycoprotein that is overexpressed by a variety of tumors such as breast, ovarian, gastric, and colorectal carcinomas. Overexpression of this oncogene is directly associated with malignant transformation of epithelial cells. The frequency of HER-2 overexpression varies among the different types of cancers, but universally represents a marker of poor prognosis. The critical role of HER-2 in epithelial oncogenesis as well as its selective overexpression on malignant tissues makes it an ideal target for immunotherapy. Antibodies and T cells reactive to HER-2 are known to naturally occur in patients with HER-2 positive tumors, confirming the immunoge…

Cellular immunitymedicine.drug_classbusiness.industryT cellmedicine.medical_treatmentImmunotherapyMonoclonal antibodymedicine.anatomical_structureImmune systemAntigenTrastuzumabImmunologyMonoclonalmedicinebusinessmedicine.drug
researchProduct

Remission of experimental autoimmune hepatitis is associated with antigen-specific and non-specific immunosuppression.

1993

SUMMARY Experimental autoimmune hepatitis (EAH) is an animal model for autoimmune hepatitis. The disease is T cell-mediated and runs a subacute course, with maximal disease activity around week four after disease induction and a slow ensuing recovery. The aim of the present study was to investigate the immunoregulatory mechanisms that may account for recovery in EAH. It was found that T cell reactivity to liver antigens preceded histological disease, but at the peak of disease activity this T cell response was already suppressed. Active and antigen-specific suppression could be demonstrated, as irradiated splenocytes from animals at the beginning of recovery from EAH were able to suppress i…

Cellular immunitymedicine.medical_treatmentT-LymphocytesImmunologyAutoimmune hepatitisBiologyHepatitis AnimalAutoimmune DiseasesMiceImmune systemAntigenmedicineImmune ToleranceTetanus ToxoidImmunology and AllergyAnimalsAntigensAutoimmune diseaseHepatitisMice Inbred BALB CImmunosuppressionT lymphocytemedicine.diseaseMice Inbred C57BLImmunologyFemaleResearch Article
researchProduct